Reviono, R. et al. 2023. Effectiveness of Zingiber officinale to reduce inflammation markers and the length of stay of patients with community-acquired pneumonia: An open-label clinical trial. Narra J. 3, 1 (May 2023), e142. DOI:https://doi.org/10.52225/narra.v3i1.142.